A UK study has found that obesity jabs could reduce health risks. 

Researchers looked at semaglutide, otherwise known as Wegovy and Ozempic, and found that the weekly shots could reduce the risk of heart attacks and strokes. 

It was found to benefit cardiovascular health even if the user didn’t lose much weight. 

UK Correspondent Gavin Grey told Roman Travers that it’s too early to say that it’s definitely working and definitely a side effect, but the potential is fascinating. 

LISTEN ABOVE